PROVIDER PROFILE · NPI 1124176102

Michele Lamantia

Internal MedicineSan Ysidro, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,435

Beneficiaries

—

Total drug cost

$159K

Distinct drugs

Brand share

38.8%

Top prescribed drugs

Hydrocodone/Acetaminophen249 claims

Pregabalin178 claims

Oxycodone Hcl/Acetaminophen138 claims

Duloxetine Hcl114 claims

Oxycodone Hcl87 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$29

Payment records

By payment type

Food and Beverage$29

REFERRAL NETWORK

Where Michele Lamantia's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 6 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CENTRO DE SALUD DE LA COMUNIDAD DE SAN YSIDRO, INC.	98	388
Unilab Corporation Clinical Laboratory · West Hills, CA	43	157

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	86	386
CENTRO DE SALUD DE LA COMUNIDAD DE SAN YSIDRO, INC.	43	105
CENTRO DE SALUD DE LA COMUNIDAD DE SAN YSIDRO, INC.	27	128
Mehran Moussavian Cardiology · Chula Vista, CA	16	64
SCRIPPS HEALTH	13	42
Mayra Dillon Family Practice · National City, CA	11	23

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history